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Abstract This study aimed to investigate the prevalence
and risk factors for anxiety and depression symptoms in
outpatient migraineurs in mainland China. In addition, we
evaluated whether the Hospital Anxiety and Depression
Scale (HADS) provided sufﬁcient validity to screen
depression and anxiety. A cross-sectional study was con-
ducted consecutively at our headache clinic. Migraine was
diagnosed according to International Classiﬁcation of
Headache Disorders, 2nd edition (ICHD-II). Demographic
characteristics and clinical features were collected by
headache questionnaire. Anxiety and depression symptoms
about migraineurs were assessed using HADS. Several
questionnaires were simultaneously used to evaluate
patients with depressive disorder including the Hamilton
Depression Rating Scale-17 (HAMD), Hamilton Anxiety
Rating Scale (HAMA) and HADS. Pearson correlation
analysis was applied to test the validity of HADS. 176
outpatients with migraine (81.8 % female) were included.
Overall, 17.6 and 38.1 % participants had depression and
anxiety, respectively. Possible risk factors for depression in
migraineurs included headache intensity of ﬁrst onset of
migraine, migraine with presymptom, migraine with family
history and migraine disability. The possible risk factors
for anxiety included ﬁxed attack time of headache in one
day and poor sleeping, and age represented a protective
factor for anxiety. The correlation coefﬁcient of HADS-A
and HADS-D with HAMA and HAMD was 0.666 and
0.508, respectively (P\0.01). This study demonstrates
that depression and anxiety comorbidity in our mainland
Chinese migraineurs are also common, and several risk
factors were identiﬁed that may provide predictive value.
These ﬁndings can help clinicians to identify and treat
anxiety and depression in order to improve migraine
management.
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Introduction
Migraine and depression are highly prevalent, and both
represent disabling diseases in populations. Studies have
found that the prevalence of migraine was 17.1 % in
females and 5.6 % in males [1]. In addition, epidemio-
logical studies found an association between migraine and
depression [2–5], indicating that the lifetime prevalence of
depression in migraine ranged from 18.8 to 42 % [2, 3, 6].
Interestingly, migraineurs were 2.2–4.0 times more likely
to suffer depression than non-migraineurs [7], and there
was an increasing suicidal tendency and attempts in
migraine with comorbid depression [8]. Breslau concluded
that association between migraine and major depression
may result from bi-directional inﬂuences; each disorder
would increase the risk for ﬁrst onset of the other [9].
Previousstudieshavealsofoundthatanxiety,particularly
general anxiety disorder, was common in migraineurs [4].
Furthermore, a study using Chinese subjects from Taiwan
found that migraine were associated with both depression
andanxiety[10]andtheonsetofanxiety typicallypreceding
the onset of migraine with the risk of depression increasing
subsequently [11]. However, due to economic and cultural
differences, the pattern in mainland China may be different
than that in Western countries or Taiwan.
Several studies supported that psychiatric comorbidities
could promote the episodic headaches transform into
chronic syndromes [12, 13]. This transformation may
increase the difﬁculty in both treatment and headache-
related disability [2]. Therefore, these ﬁndings indicate that
psychiatric comorbidity must be treated in timely manner;
however, the identiﬁcation and diagnosis of psychiatric
comorbidity in migraineurs is much lower, especially in
China. Understanding the risk factors associated with
depression and anxiety in migraineurs will provide helpful
information for clinicians to prevent and treat these disor-
ders. To date, only a few studies have examined the
demographics and clinical features in patients with head-
aches associated with depression [14, 15], and no studies
have investigated the risk factors for depression and anxi-
ety in migraineurs.
The Hospital Anxiety and Depression Scale (HADS) is a
fast screening tool, to screen depression and anxiety symp-
toms in somatic, psychiatric and primary care patients [16].
Therefore, the purpose of our study was to assess the
prevalence and risk factors for anxiety and depression in
migraine outpatients in mainland China. In addition, we
also tested the validity of the HADS to determine whether
this tool displays sufﬁcient validity to screen depression
and anxiety symptoms in migraineurs.
Methods
Subjects and procedures
One hundred and eighty-ﬁve consecutive migraine patients
were included in this study. These patients visited the
headache outpatient clinic in the First Afﬁliated Hospital of
Chongqing Medical University in China from September
2009 to January 2011. Migraine diagnosis was conducted
by a neurologist according to the ICHD-II [17], and the
diagnosis was conﬁrmed by a headache specialist. The
following criteria were also utilized. The course of
migraine must be more than 1 year. Subjects were exclu-
ded if they had experienced signiﬁcant life-changing events
(e.g. seeing others being killed, death and serious injury;
hearing some terrible things; being raped; being divorced,
etc.) recently [18], or were prescribed antidepressants or
other psychotropic drugs in the past 2 weeks. According to
these criteria, nine patients were excluded from the study,
and 176 people included in the ﬁnal study. 94.3 % of the
subjects were of Chinese Han ethnicity.
To test the validity of the HADS, 30 consecutive major
depression disorder patients (66.7 % female) were included
who visited the psychiatry department in the same hospital
from January 2011 to May 2011. The age of the subjects
ranged from 20 to 59 years (average 36.5 ± 10.9 years).
Depression was diagnosed by a psychiatry specialist
according to the Structured Clinical Interview provided in
the DSM-IV-text revision (TR) Axis I Disorders [18]. The
patients were also assessed by a psychiatrist. 98 % of the
subjects were of Chinese Han ethnicity.
The study protocol was approved by the Ethical Com-
mittee at Chongqing Medical University and in accordance
with the Declaration of Helsinki. All patients had given
written consent to the study.
All headache information was collected by three neu-
rologists through face-to-face interviews. The ﬁndings
were then reviewed by a headache specialist, and anxiety
and depression symptoms of the migraineurs were assessed
by a psychiatrist. Demographic characteristics and clinical
features were collected using a headache questionnaire.
Demographic characteristics included age, sex, employ-
ment status, educational level (four categories: B6, 7–9,
10–12, [12 years), dwelling (three categories: living in
town, in suburban area, in countryside) etc.; and clinical
features of the migraine headache included the ﬁrst onset
age, headache pain intensity, headache nature, locus,
duration, presymptom (e.g., ﬂuctuating mood, drowsiness,
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123reduced activity, yawning, desire to eat, neck tightness,
etc.), the average monthly headache frequency in the recent
3 months, family migraine history (ﬁrst-degree relatives),
migraine disability, sleeping (i.e., excellent, better, bad,
worst), etc. Finally, a question about life events (Were
there any events which were difﬁcult to handle that inﬂu-
enced your mood in the last month?) was included as well
as the psychiatry medication history in the past 2 weeks.
Measures
Headache pain intensity was assessed by an 11-point pain
scale (0–10) with 0 indicating ‘‘no headache’’ and 10
indicating ‘‘headache as severe as I can imagine’’ [19]. 1–3
was deﬁned as ‘‘mild’’; 4–6 as ‘‘moderate’’; and 7–10 as
‘‘severe’’. Migraine-related disability was assessed by The
Migraine Disability Assessment questionnaire (MIDAS)
[20]. Participants were divided into four grades by MIDAS
using previously validated scores based on lost-time due to
headaches (i.e., minimal, mild, moderate, and severe dis-
ability). In addition, ICHD-II was also applied to divide the
patients into subgroups, and the subgroups included
migraine with aura (MA) and migraine without aura
(MOA) or episodic migraine (EM) and chronic migraine
(CM) [17].
Anxiety and depression were assessed utilizing HADS
[16]. It is a well-established self-rating instrument with 14
items, and incorporates seven anxiety questions (HADS-A)
and seven depression questions (HADS-D). Each item is
scored from 0 (not present) to 3 (maximally present),
representing a 4-point scale. Because the total score of each
subscale is 21, the total score of each subscale that is
greater than eight indicates that the person may have
anxiety (ANX) or depression (DEP) symptoms. If the total
score of HADS-D C8 and HADS-A \8, the person has
pure depressive symptoms (pure DEP). If the total score of
HADS-A C8 and HADS-D\8, the person has pure anxiety
symptoms (pure ANX). When the total score of both
HADS-A and HADS-D C8, it accounts for that the person
has comorbid symptoms (COM). Previous studies indicated
that the correlation of HADS-D and HADS-A with other
commonly used anxiety and depression questionnaires such
as Beck Depression Inventory(BDI), State-Trait Anxiety
Inventory (STAI), and SCL-90 Anxiety and Depression
subscales, respectively, were between 0.60 and 0.80, the
validity and reliability of HADS are good [21, 22].
In order to check the validity of HADS in Chinese
subjects, we simultaneously evaluated major depression
disorder patients using the Hamilton Depression Rating
Scale-17 (HAMD-17), Hamilton Anxiety Rating Scale
(HAMA), and HADS. Previous studies have found that
HAMD and HAMA also have good valid and reliability
[23–25].
Statistical analysis
All data were analyzed using the SPSS 17.0 statistics
package. Continuous variables data were expressed as
mean ± SD. One-way ANOVA and v
2 tests were used for
comparison when appropriate. We used binary logistic
regression to calculate the odds ratios (ORs) for pure DEP,
pure ANX and COM in persons having EM and CM, and
also analyzed both genders. We evaluated potential con-
founding by adjusting for age and education, and investi-
gated potential interaction effects between gender and pure
DEP, pure ANX and COM by including the product of the
two variables in the logistic regression analyses. We used
the Wald v
2 statistic to test the interaction coefﬁcients.
When analyzing the risk factors for depression or anx-
iety in migraineurs, we used binary logistic regression with
a backward progression. The dependent variable was the
presence or absence of depression or anxiety symptoms.
The 18 independent variables consisted of the following:
age (three categories: \30, 30–45, [45 years), gender,
educational years, profession, dwelling, the ﬁrst-onset age
of migraine (\20, 20–35, [35 years), headache pain
intensity of ﬁrst onset of migraine (none, mild, moderate,
severe), average monthly headache frequency in the recent
3 months (B8, 9–14, C15 days per month), frequency of
headache in 1 year (\1, 2–3, 4–6, [6 months), the most
painful degree (none, mild, moderate, severe), ﬁxed attack
time in one day (yes/no), ﬁxed attack time on year (yes/no),
presymptom, course of disease (B15, 16–30, [30 years),
sleeping, family history of migraine (yes/no), migraine
disability (minimal, mild, moderate, severe), and headache
pain intensity of migraine now (none, mild, moderate,
severe).
When checking the validity of the HADS, the normality
of data was ﬁrst tested for HAMD, HAMA, and HADS,
and the results indicated that all demonstrated normal
distributions. We then used the Pearson product-moment
correlation analysis to analyze the correlation of HADS-A
and HADS-D with HAMA and HAMD.
A signiﬁcance level of P\0.05 was chosen in all sta-
tistical hypotheses, and all statistical tests were two-sided.
Results
Migraine characteristics
The migraine samples including 144 (81.8 %) females and
32 (18.2 %) males, ranging in age from 14 to 63 years
(average 39.1 ± 11.6 years). The average ﬁrst-onset age of
migraine was 23.8 ± 10.3 years. The average course of
migraine was 15.4 ± 11.0 years. The headache frequency
during the last 3 months were 106 patients (60.2 %) with
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123B8 days/month, 17 (9.7 %) with 9–14 days/month, and 53
patients (30.1 %) with C15 days/month. A signiﬁcant dif-
ference was observed for depression and anxiety in dif-
ferent frequency of headache (DEP: F = 3.11, P = 0.047;
ANX: F = 3.48, P = 0.033). Our results indicated that the
seriousness of depression and anxiety symptoms were
correlated with the frequency of the headache. The average
intensity score of the headache in a recent month was
7.4 ± 1.3. The migraine subtypes are shown in Table 1.
Depression symptoms and anxiety symptoms
in migraineurs
The average depression score of migraineurs was 4.4 ±
3.6, and depression symptoms (DEP) occurred in 17.6 %
(31 of 176). The prevalence rate of depression symptoms in
females was twice than that in males (19.4 vs. 9.4 %), but
no signiﬁcant difference was found between sex (P[0.05).
The prevalence rate of depression symptoms in MOA was
17.1 % (26 of 152), in MA was 20.8 % (5 of 24); and
13.8 % (17 of 123) in EM, 26.4 % (14 of 53) in CM.
A signiﬁcant difference of prevalence rate was detected in
depression symptoms between EM and CM (v
2 = 4.05,
P = 0.044).
The average anxiety score of migraineurs was 6.5 ±
3.8. Anxiety symptoms (ANX) occurred in 38.1 % (67 of
176). The prevalence rate of anxiety symptoms in females
was higher than in males (41.9 vs. 25.0 %), but no sig-
niﬁcant difference was observed between sex (P[0.05).
The prevalence rate of anxiety symptoms in MOA was
37.5 % (57 of 152), in MA was 41.7 % (10 of 24); and
33.3 % (41 of 123) in EM, 49.1 % (26 of 53) in CM, there
was signiﬁcant difference between EM and CM (v
2 = 3.88,
P = 0.049).
In all migraine patients there were only 2.8 % comorbid
pure DEP, 23.3 % comorbid pure ANX, and 14.8 %
comorbid both DEP and ANX. Depression and anxiety
symptoms were more common in females (Table 1).The
odds ratio of pure DEP, pure ANX and COM prevalence in
persons with CM compared to EM are shown in Table 2.
COM was more likely to occur in CM, especially in
females having CM rather than in those with EM. No
Table 1 The subtypes of migraine and the depression and anxiety symptoms in migraineurs, N (%)
N (%) MOA MA EM CM No mental disorder Pure DEP Pure ANX COM
Total 176 (100) 152 (86.4) 24 (13.6) 123 (69.9) 53 (30.1) 104 (59.1) 5 (2.8) 41 (23.3) 26 (14.8)
Male 32 (18.2) 24 (75) 8 (25) 22 (68.8) 10 (31.3) 24 (75.0) 0 (0) 5 (15.6) 3 (9.4)
Female 144 (81.8) 128 (88.9) 16 (11.1) 101 (70.1) 43 (29.9) 80 (55.6) 5 (3.5) 36 (25.0) 23 (16.0)
MOA migraine without aura, MA migraine with aura, EM episode migraine, CM chronic migraine, DEP depressive symptoms, ANX anxiety
symptoms, COM comorbid depressive and anxiety symptoms
Table 2 The odds ratio of pure depression symptoms, pure anxiety symptoms and comorbid symptoms prevalence in patients with CM
compared with EM
Variance HADS nP OR 95 % CI
CM 53
Both genders No disorder 24 1
Pure DEP 3 0.068 6.39 0.87, 46.99
Pure ANX 15 0.055 2.34 0.98, 5.57
COM 11 0.011 3.72 1.35, 10.28
Male No disorder 6 1
Pure DEP 0
Pure ANX 2 0.692 0.45 0.01, 23.53
COM 2 0.743 2.02 0.03, 133.74
Female No disorder 18 1
Pure DEP 3 0.070 6.23 0.86, 44.90
Pure ANX 13 0.091 2.21 0.88, 5.51
COM 9 0.049 2.95 1.00, 8.68
All numbers were adjusted for age, and education. Gender interaction was tested: gender 9 pure DEP, P = 0.091; gender 9 pure ANX,
P = 0.663; gender 9 COM, P = 0.234
DEP depressive symptoms, ANX anxiety symptoms, COM comorbid depressive and anxiety symptoms
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123signiﬁcant associations were found between pure DEP and
pure ANX in either the CM or EM groups.
Risk factors for depression in migraineurs
Logistic regression analysis revealed that the following
four factors were associated with depression in migrai-
neurs: (1) headache intensity of ﬁrst onset of migraine, (2)
presymptom of migraine (mainly including: ﬂuctuating
mood, drowsiness, reduced activity, yawning), (3) migraine
family history, and (4) migraine disability. We found the
moderate headache intensity was the highest risk factor for
depression as compared to mild and severe headache
intensity in ﬁrst onset of migraine. Presymptom and family
migraine history were also risk factors for depression; and
the mild, moderate and severe disability were all signiﬁ-
cantly different than minimal disability on the outcome
measure for depression (Table 3).
Risk factors for anxiety in migraineurs
Logistic regression analysis revealed that age was a pro-
tective factor for anxiety. For example, a lower incidence
of anxiety was correlated with the increasing age of the
patient. However, ﬁxed attack time of headache in one day
and poor sleeping were the risk factors associated with
anxiety in migraineurs (Table 4).
Validity of HADS
Correlation analysis was used to analyze the results of
HAMD, HAMA and HADS from the patients of major
depression disorder, and the results of the correlation
coefﬁcientofHADS-AwithHAMAwas0.666andHADS-D
with HAMD was 0.508 (Table 5). Of these 30 major
depressive disorder patients 27 patients had the total score
of HADS-D C8, so the sensitivity of HADS-D was 90 %
(27/30); and there were 26 patients with a total score of
HADS-A C8, so the sensitivity of HADS-A was 86.7 %
(26/30).
Discussion
Incidence of depression and anxiety symptoms
In our headache outpatient clinic, we used HADS to detect
depression and anxiety symptoms in migraine patients. The
results found that the incidence of depression symptoms
was 17.6 %. This ﬁnding was lower than the rates observed
in other clinical studies, including 20 % seen in UK [26]
and 23.1 % seen in Italy [27], and are also lower than the
rate in a population-based study which ranged from 28.5 to
42 % in USA [4, 5]. Wang [10] investigated the prevalence
of depression in the elderly headache patients in Taiwan,
and found that the prevalence of depression was 13.4 %;
however, headache subtypes were not examined. The
incidence of anxiety symptoms was 38.1 % in our samples,
which was similar to the results of a study from Italy
(38.1 %) [27], but lower than a population-based study
(51 %) from the USA [28].
These differences may result from inherent differences
associated with race and culture [29] or different evaluation
instruments. Chinese culture tends to express depression
somatically (e.g., fatigue, sleep problems, headache, mus-
cle pain, etc.), but tends to deny psychological symptoms,
especially depression. Therefore, depression has lower rate
Table 3 Risk factors for depression in migraineurs, analyzed by
Binary backward logistic regression
Variance P OR 95.0 % CI
Headache intensity of ﬁrst onset
Mild 1
Moderate 0.037 4.86 1.10, 21.56
Severe 0.248 2.34 0.49, 11.13
Presymptom of migraine
No 1
Yes 0.007 7.78 1.75, 34.63
Family migraine history
No 1
Yes 0.017 3.38 1.25, 9.14
Migraine disability
Minimal 1
Mild 0.039 3.60 1.07, 12.15
Moderate 0.014 5.03 1.39, 18.25
Severe 0.014 5.12 1.40, 18.79
Table 4 Risk factors for anxiety in migraineurs, analyzed by binary
backward logistic regression
Variance P OR 95.0 % CI
Age
\30 years 1
30–45 years 0.003 0.19 0.06, 0.56
[45 years 0.018 0.25 0.08, 0.79
Fixed attack time of headache in one day
No 1
Yes 0.016 4.26 1.30, 13.94
Sleeping
Excellent 1
Better 0.297 2.52 0.44, 14.26
Bad 0.004 13.46 2.30, 78.87
Worst 0.003 36.34 3.38, 390.99
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123of detection and diagnosis, and is easily misdiagnosed as
neurasthenia [30, 31]. In our study, when we informed
patients that we would assess their depression and anxiety
status, some patients felt irritated and denied that they had
a psychiatric disorder, and they tried to refuse the assess-
ment. However, when investigators explained that it was
just a mood assessment and told them that the correct
assessment could help to treat their headache, the patients
agreed to comply. When they were completing the ques-
tionnaire, they seemed to avoid of expressing their real
depressive mood.
The seven depression items of HADS mainly assess the
mood symptoms including lowered mood, anhedonia, and
psychomotor retardation; however, HADS lacks assess-
ment items regarding somatic symptoms. In previous
studies, DSM-IV, HAMD, HAMA, or Beck Depression
Inventory (BDI) were used to evaluate mood, which con-
tain items about somatic symptoms [2, 3]. Therefore, the
use of HADS in our study to a certain extent may have led
to our lower detection rate of depression.
The validity of HADS
Previous studies indicated that HADS is a valid and reli-
able instrument to screen for depression and anxiety
symptoms [21]. Furthermore, Juang [22] found that HADS
was a valid and reliable in a study of headache patients in
Taiwan. Because this test requires less time to complete,
we used HADS to evaluated depression and anxiety
symptoms in migraineurs. As our rate of depression or
anxiety symptoms was lower than previous studies, we
questioned whether HADS represented a valid measure.
Therefore, we compared the ﬁndings from HADS to that of
HAMD and HAMA in patients with major depression
disorder. The correlation coefﬁcient of HADS-A and
HADS-D with HAMA and HAMD were 0.666 and 0.508,
respectively, similar to previous study [21]. But the cor-
relation of HADS-D with HAMD was somewhat lower,
although the sensitivity of HADS-D was good; this might
be the cause that led to lower detection results in our study.
Therefore, our ﬁndings suggest that future studies could
utilize BDI and Beck Anxiety Inventory (BAI) or HAMD
and HAMA to evaluate depression or anxiety symptoms in
migraineurs. These scales represent professional assess-
ment scales that have a better validity and reliability [24,
25, 32].
The relationship of the DEP and ANX with migraine
characteristics and subgroups
Our study demonstrates that migraine was associated with
depression and anxiety, and the prevalence was higher in
females than males, which is consistent with the previous
studies [2, 3]. Moreover, the prevalence of depression and
anxiety in the general population was also higher in
females than in males [33]. We observed that frequency of
headaches was associated with more serious depression and
anxiety symptoms in agreement with Mitsikostas’ results
[34]. We also found a stronger relationship of COM with
CM than with EM. These results indicate that doctors
should check whether the patient has comorbid depression
or anxiety symptoms if headaches occur frequently in a
migraineur, especially to be vigilant in managing the COM
in CM.
Risk factors for DEP and ANX in patients
with migraine
Fewer studies explored the risk factors for mental disorder
in migraineurs. In this study, we found that only moderate
headache among the ﬁrst onset of migraine was associated
with depression. This result was contrary to those of
Mitsikostas’ study [34] where the frequency and the
duration of the headache attacks were signiﬁcantly asso-
ciated with depression or anxiety, not the intensity of
headache. However, he did not divide the headache into
subtypes, and the degree of headache with ﬁrst onset of
migraine may be confounded by recall bias in our study,
potentially leading to this discrepancy.
We also found that headache-related disability was a
risk factor for depression consistent with Jelinski’s study
[14], who observed that severe headache-related disability
was independently associated with depression. However,
he did not divide the headache into subtypes either. In
addition, we discovered another two risk factors for
depressionincludingthefamilymigrainehistory(ﬁrst-degree
Table 5 Pearson correlation coefﬁcients of HADS-D and HADS-A with HAMD and HAMA
HAMA HAMD HADS-A HADS-D
HADS-A 0.666
a 0.506
a 1.000 0.631
a
HADS-D 0.581
a 0.508
a 0.631
a 1.000
HADS-A Hospital Anxiety and Depression Scale (anxiety subscale), HADS-D Hospital Anxiety and Depression Scale (depression subscale),
HAMA Hamilton anxiety rating scale, HAMD Hamilton depression rating scale-17
a Correlation is signiﬁcant at the 0.01 level (2-tailed)
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mood, drowsiness, reduced activity, yawning). Merikangas
[35] found a signiﬁcant association between migraine and
depression in both probands as well as the relatives. In our
study, we observed that patients were more likely to suffer
from depression if the patients had a family history of
migraines.
We also found that the perception of presymptoms of
migraine enabled patients to forecast headache attacks in
advance, a ﬁnding that has not yet been reported in pre-
vious studies. This perception may induce a patient’s fear
of headache and depression symptoms. In this ﬁnding also
exists a confounding factor, ﬂuctuating mood, which is one
of the presymptoms of migraine that might be assessed in
the outcome measure and hence be a possible confounder.
Even so, clinicians should note depression symptoms if
migraine patients present presymptoms for a better and
timely treatment.
We only found two factors that were independent risk
factors for anxiety including a ﬁxed attack time of head-
ache in one day and poor sleeping. Frisoni’s study [36]
indicated that anxiety was independently associated with
quality of sleep. In addition, Morrison [37] investigated
sleep problems in 943 adolescents from the general popu-
lation, and found that adolescents reporting sleep problems
were more anxious and depressed. To date, no studies have
identiﬁed a relationship between ﬁxed attack time and
mood disorders, which is potentially related to the ﬂuctu-
ations of ovarian hormones [38]. Interestingly, we observed
that age was a protective factor for anxiety. Only one
investigation reported a decrease of depression disorder
prevalence in older age groups [2].
The necessity of treatment for mental disorder
Migraine and depression signiﬁcantly decrease the quality
of life [2] and lead to a worse prognosis, chronic disease,
and a decreased response to treatment [39]. Pesa [40]
indicated that migraine comorbid with depression or anx-
iety also results in signiﬁcantly higher medical costs as
compared to migraine alone. Therefore, early diagnosis and
treatment for psychiatric comorbidity are very important. If
comorbid depression is not recognized and treated effec-
tively, successful headache management is unlikely. Fur-
thermore, it is obviously not appropriate for doctors to
exclusively focus on the treatment of headache symptoms
of migraine patients and neglect the psychiatric comor-
bidity under the traditional medical model. When treating
migraine headaches, clinicians should be alert to psychi-
atric comorbidity, and then treat psychiatric comorbidity in
a timely manner in order to prevent the functional lesion of
migraineurs. This strategy would certainly be beneﬁcial to
the improvement of their life quality.
Limitations
Our study has some methodological limitations. First,
migraine patients in our study were limited to those who
did not have great life events recently and those who had
not taken antidepressants or other psychotropic drugs in the
past 2 weeks. The purpose of these exclusion criteria was
to prevent confounders that may affect the mood charac-
teristics. Second, the sample size was not large enough to
detect a difference between MA and MOA. Third, we
checked the validity of HADS only in major depression
disorder patients in our psychiatric department, but not in
migraine patients. We believed that the results would be
more accurate if the validity of the HADS was evaluated
among patients that were exactly diagnosed with major
depression disorder.
This study has several clinical implications. First, the
comorbidity of depression and anxiety in mainland Chinese
migraineurs is common. When clinicians treat headache of
migraine, they should pay close attention to psychiatric
comorbidity, and treat these disorders in a timely manner.
Second, as our results suggest, multiple risk factors are
associated with depression and anxiety in migraineurs.
Thus, when migraineurs come to seek help from clinician,
clinicians should pay attention to these factors because
these risk factors can be helpful for predicting and identi-
fying mood symptoms.
Acknowledgments The authors are grateful for the support of the
Natural Science Foundation of China (Grant No. 30970988) and
Medical Scientiﬁc Research Program of Chongqing Municipal Health
Bureau (Grant Nos. 2009-2-31 and 2010-2-087). Funding was from
Natural Science Foundation of China (Grant No. 30970988) and
Medical Scientiﬁc research Program of Chongqing Municipal Health
Bureau (Grant Nos. 2009-2-31 and 2010-2-087).
Conﬂict of interest None.
Open Access This article is distributed under the terms of the
Creative Commons Attribution License which permits any use, dis-
tribution, and reproduction in any medium, provided the original
author(s) and the source are credited.
References
1. Lipton RB, Bigal ME, Diamond M, Freitag F, Reed ML, Stewart
WF (2007) Migraine: prevalence, disease burden, and the need
for preventive therapy. Neurology 68:343–349. doi:10.1212/01.
wnl.0000252808.97649.21
2. Jette N, Patten S, Williams J, Becker M, Wiebe S (2008)
Comorbidity of migraine and psychiatric disorders—a national
population-basedstudy.Headache48:501–516.doi:10.1111/j.1526-
4610.2007.00993.x
3. Molgat CV, Patten SB (2005) Comorbidity of major depression
and migraine—A Canadian population-based study. Can J Psy-
chiatry 50:832–837
J Headache Pain (2012) 13:303–310 309
1234. Antonaci F, Nappi G, Galli F, Manzoni GC, Calabresi P, Costa A
(2011) Migraine and psychiatric comorbidity: a review of clinical
ﬁndings. J Headache Pain 12(2):115–125. doi:10.1007/s10194-
010-0282-4
5. Breslau N, Andreski P (1995) Migraine, personality and psychi-
atric comorbidity. Headache 35:382–386. doi:10.1111/j.1526-
4610.1995.hed3507382.x
6. Tietjen GE, Peterlin BL, Brandes JL, Hafeez F, Hutchinson S,
Martin VT et al (2007) Depression and anxiety: effect on the
migraine–obesity relationship. Headache 47:866–875. doi:10.
1111/j.1526-4610.2007.00810.x
7. Hamelsky SW, Lipton RB (2006) Psychiatric comorbidity of
migraine. Headache 46:1327–1333. doi:10.1111/j.1526-4610.
2006.00576.x
8. Breslau N, Davis GC, Andreski P (1991) Migraine, psychiatric
disorders, and suicide attempts: an epidemiologic study of young
adults. Psychiatry Res 37(1):11–23. doi:10.1016/0165-1781
(91)90102-U
9. Breslau N, Lipton RB, Stewart WF, Schultz LR, Welch KMA
(2003) Comorbidity of migraine and depression. Neurology
60(8):1308–1312. doi:10.1212/01.WNL.0000058907
10. Wang SJ, Liu HC, Fuh JL, Liu CY, Wang PN, Lu SR (1999)
Comorbidity of headaches and depression in the elderly. Pain
82:239–243. doi:10.1016/S0304-3959(99)00057-3
11. Mercante JPP, Peres MFP, Bernik MA, Corchs F, Guendler VZ,
Zukerman E (2011) Disease progression to chronic migraine:
onset of symptoms of headaches, anxiety and mood disorders.
Headache Med 2(1):5–9
12. Lipton RB, Pan J (2004) Is migraine a progressive brain disease?
JAMA 291:493–494. doi:10.1001/jama.291.4.493
13. Scher AI, Lipton RB, Stewart W (2002) Risk factors for chronic
daily headache. Curr Pain Headache Rep 6:486–491. doi:
10.1007/s11916-002-0068-8
14. Jelinski SE, Magnusson JE, Becker WJ, CHORD Study Group
(2007) Factors associated with depression in patients referred to
headache specialists. Neurology 68:489–895. doi:10.1212/01.
wnl.0000253183.57001.b3
15. Chung MK, Kraybill DE (1990) Headache: a marker of depres-
sion. J Fam Pract 31:360–364
16. Zigmond AS, Snaith RP (1983) The Hospital Anxiety and
Depression Scale. Acta Psychiatr Scand 67:361–370. doi:
10.1111/j.1600-0447.1983.tb09716.x
17. The international classiﬁcation of headache disorders: 2nd edition
(2004). Cephalalgia 24 Suppl 1:9–160
18. First MB, Spitzer RL, Gibbon M, Williams JBW (2002) Struc-
tured clinical interview for DSM-IV-TR Axis I disorders, research
version, patient edition (SCID-I/P). Biometrics Research, New
York State Psychiatric Institute, New York
19. Kwong WJ, Pathak DS (2007) Validation of the eleven-point pain
scale in the measurement of migraine headache pain. Cephalalgia
27:336–342. doi:10.1111/j.1468-2982.2007.01283.x
20. Stewart WF, Lipton RB, Dowson AJ, Sawyer J (2001) Devel-
opment and testing of the migraine disability assessment
(MIDAS) questionnaire to assess headache-related disability.
Neurology 56(suppl 1):S20–S28
21. Bjelland I, Dahl AA, Haug TT, Neckelman D (2002) The validity
of the Hospital Anxiety and Depression Scale. An updated lit-
erature review. J Psychosom Res 52(2):69–77. doi:10.1016/
S0022-3999(01)00296-3
22. Juang KD, Wang SJ, Lin CH, Fuh JL (1999) Use of the hospital
anxiety and depression scale as a screening tool for patients with
headache. Zhonghua Yi Xue Za Zhi (Taipei) 62:749–755
23. Hamilton M (1967) Development of a rating scale for primary
depressive illness. Br J Soc Clin Psychol 6(4):278–296
24. Miller IW, Bishop S, Norman WH, Maddever H (1985) The
Modiﬁed Hamilton Rating Scale for Depression: reliability and
validity. Psychiatry Res 4:131–142. doi:10.1016/0165-1781
(85)90057-5
25. Maier W, Buller R, Philipp M, Heuser I (1988) The Hamilton
Anxiety Scale: reliability, validity and sensitivity to change in
anxiety and depressive disorders. J Affect Disord 14:61–68. doi:
10.1016/0165-0327(88)90072-9
26. Devlen J (1994) Anxiety and depression in migraine. J ROY SOC
MED 87(6):338–341
27. Beghi E, Bussone G, Amico DD, Cortelli P, Cevoli S, Manzoni
GC et al (2010) Headache, anxiety and depressive disorders: the
HADAS study. J Headache Pain 11:141–150. doi:10.1007/
s10194-010-0187-2
28. Breslau N (1998) Psychiatry comorbidity in migraine. Cepha-
lalgia 18(Suppl 22):S56–S61
29. Ryder AG, Yang J, Heine SJ (2002) Somatization versus psy-
chologization of emotional distress: A paradigmatic example for
cultural psychopathology. In: Lonner WJ, Dinnel DL, Hayes SA,
Sattler DN (eds), Online readings in psychology and culture (9th
ed). Bellingham
30. Lin TY (1989) Neurasthenia revisited: its place in modern psy-
chiatry. Cult Med Psychiatry 13:105–129. doi:10.1007/BF02220
656
31. Chan B, Parker G (2004) Some recommendations to assess
depression in Chinese people in Australasia. Aust NZ J Psychi-
atry 38:141–147. doi:10.1111/j.1440-1614.2004.01321.x
32. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J (1961) An
inventory for measuring depression. Arch Gen Psychiatry
4:561–571
33. Kessler RC, Berglund P, Demler O, Jin R, Koretz D, Merikangas
KR et al (2003) The epidemiology of major depressive disorder.
Results from the national comorbidity survey replication (NCS-
R). JAMA 289:3095–3105
34. Mitsikostas DD, Thomas AM (1999) Comorbidity of headache
and depressive disorders. Cephalalgia 19:211–217. doi:
10.1046/j.1468-2982.1999.019004211.x
35. Merikangas KR, Risch NJ, Merikangas JR, Weissman MM, Kidd
KK (1988) Migraine and depression: association and familial
transmission. J Psychiatr Res 22:119–129. doi:10.1016/0022-
3956(88)90076-3
36. Frisoni GB, Leo Dd, Rozzini R, Bernardini M, Buono MD,
Trabucchi M (1992) Psychic correlates of sleep symptoms in the
elderly. Int J Geriatric Psychiatry 7:891–898. doi:10.1002/
gps930071208
37. Morrison DN, McGee R, Stanton WR (1992) Sleep problems in
adolescence. J Am Acad Child Adolesc Psychiatry 31:94–99. doi:
10.1097/00004583-199201000-00014
38. Baskin SM, Smitherman TA (2009) Migraine and psychiatric
disorders: comorbidities, mechanisms, and clinical applications.
Neurol Sci 30(Suppl 1):S61–S65. doi:10.1007/s10072-009-
0071-5
39. Pompili M, Cosimo DD, Innamorati M, Lester D, Tatarelli R,
Martelletti P (2009) Psychiatric comorbidity in patients with
chronic daily headache and migraine: a selective overview
including personality traits and suicide risk. J Headache Pain
10(4):283–290. doi:10.1007/s10194-009-0134-2
40. Pesa J, Lage MJ (2004) The medical costs of migraine and
comorbid anxiety and depression. Headache 44:562–570. doi:
10.1111/j.1526-4610.2004.446004.x
310 J Headache Pain (2012) 13:303–310
123